Drug Safety

Acknowledgement

Do Non-Nucleoside Reverse Transcriptase Inhibitors Contribute to Lipodystrophy?

David Nolan

Sex Differences in Antiretroviral Therapy-Associated Intolerance and Adverse Events

Rebecca Clark

Therapy for Menopausal Symptoms During and After Treatment for Breast Cancer

Rodney Baber, Martha Hickey, Michelle Kwik

The Safety and Efficacy of Desloratadine for the Management of Allergic Disease

William E. Berger

Influence of Computerised Medication Charts on Medication Errors in a Hospital

Dieuwke G. van Gijssel-Wiersma, Patricia M.L.A van den Bemt, Monique C.M. Walenbergh-van Veen

Clinical Relevance of Drug-Drug Interactions

Eric N. van Roon, Sander Flikweert, Marianne le Comte, Pim N.J. Langendijk, Wilma J.M. Kwee-Zuiderwijk, Paul Smits, Jacobus R.B.J. Brouwers

Effect of Concomitant Use of Benzodiazepines and Other Drugs on the Risk of Injury in a Veterans Population

Dustin D. French, Thomas N. Chirikos, Andrea Spehar, Robert Campbell, Heidi Means, Tatjana Bulat

Effects of the Committee on Safety of Medicines Advice on Antidepressant Prescribing to Children and Adolescents in the UK

Macey L. Murray, Mary Thompson, Paramala J. Santosh, Ian C.K. Wong

A New Algorithm to Identify the Causality of Adverse Drug Reactions

Yvonne Koh, Shu Chuen Li